公开(公告)号：US09314483B2

公开(公告)日：2016-04-19

申请号：US14303212

申请日：2014-06-12

Applicant: YEDA RESEARCH AND DEVELOPMENT CO., LTD.

Inventor： Michal Eisenbach-Schwartz ,  Ester Yoles ,  Ravid Shechter ,  Omer Miller

IPC: C12N5/0786 ,  A61K35/15 ,  A61K35/14 ,  A61K35/12

CPC classification number: A61K35/15 ,  A61K35/14 ,  A61K2035/124 ,  C12N5/0645

Abstract: A subpopulation of peripheral blood mononuclear cells (PBMCs) that is substantially devoid of CD3+ cells, CD19+ cells, CD56+ cells and optionally of CD16+ cells, for use in treatment of CNS injury is provided.

Abstract translation: 提供了用于治疗CNS损伤的基本上不含CD3 +细胞，CD19 +细胞，CD56 +细胞和任选的CD16 +细胞的外周血单核细胞（PBMC）的亚群。